Oral malodor represents a common health concern affecting a substantial portion of the global population, the prevalence of which can range from 15% to 60%, highlighting its widespread occurrence. Bad breath, originating from pathogens in the oral cavity, can be mediated through treatment with antibacterial mouthwashes. This clinical trial explores the antibacterial effects and anti-malodor properties of a mouthwash containing both cetylpyridinium chloride and zinc lactate (CPC + Zn).
Schaeffer et al. (Mon,) studied this question.